Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
---|---|---|---|---|---|
ARCH Venture Partners IX, LLC | 10%+ Owner | $83M | Jun 21, 2021 | ||
Robert Nelsen | Director, 10%+ Owner | $83M | Jun 14, 2024 | ||
GSK plc | 10%+ Owner | $69M | Jun 21, 2021 | ||
Hans Edgar Bishop | Director | $10.7M | Jun 14, 2024 | ||
Richard Klausner | Director | $8.33M | Jun 14, 2024 | ||
Cathy Friedman | Director | $767K | Jun 14, 2024 | ||
Lynn Seely | President and CEO, Director | $456K | Feb 9, 2024 | ||
Gary K. Lee | Chief Scientific Officer | $120K | Feb 9, 2024 | ||
Matthew Lang | Chief Business Officer | $114K | Feb 9, 2024 | ||
Stephen J. Hill | Chief Operating Officer | $112K | Feb 9, 2024 | ||
Charles W. Newton | Chief Financial Officer | $111K | Feb 9, 2024 | ||
Tina M. Albertson | Chief Medical Officer | $9.23K | Feb 24, 2023 | ||
Elizabeth Homans | Chief Executive Officer, Director | Mar 16, 2022 | |||
William Jl Rieflin | Director | Jun 14, 2024 | |||
Otis W. Brawley | Director | Jun 14, 2024 | |||
Rahsaan Thompson | Chief Legal Officer | Feb 24, 2023 | |||
Heather Turner | Chief General Counsel | Mar 16, 2022 | |||
Elizabeth G. Nabel | Director | Jun 14, 2024 |
Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
---|